Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.40 |
| ▸ | SQLE | Q14534 | 6/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11558624 | 1.00 | KMT2A (0.44) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL7158021 | 0.82 | KMT2A (0.44) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL11384039 | 0.80 | KMT2A (0.43) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL16485911 | 0.77 | TSHR (0.37) | TSHR | |
| SCHEMBL11560319 | 0.77 | KMT2A (0.40) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL3017518 | 0.77 | KMT2A (0.40) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL3640419 | 0.74 | ALDH1A1 (0.39) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL3640422 | 0.74 | ALDH1A1 (0.39) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL7567993 | 0.73 | TSHR (0.50) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL8464166 | 0.72 | KMT2A (0.55) | KMT2AMEN1CYP3A4ALOX15MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2346816-B1 | Chemically stable ingredients as lemon odorant | FIRMENICH & CIE (CH) | 2013-01-23 | — | — | EP | disclosed |
| US-8313736-B2 | Chemically stable ingredients as lemon odorant | FIRMENICH SA (CH) | 2012-11-20 | — | — | US | disclosed |
| US-20120003170-A1 | CHEMICALLY STABLE INGREDIENTS AS LEMON ODORANT | FIRMENICH SA (CH) | 2012-01-05 | — | — | US | disclosed |
| EP-2346816-A1 | CHEMICALLY STABLE INGREDIENTS AS LEMON ODORANT | Firmenich S.A. (CH) | 2011-07-27 | — | — | EP | disclosed |
| WO-2011033410-A1 | NITRILE COMPOUNDS AS PERFUMING INGREDIENTS | FIRMENICH SA (CH) | 2011-03-24 | — | — | WO | disclosed |
| WO-2010044031-A1 | CHEMICALLY STABLE INGREDIENTS AS LEMON ODORANT | FIRMENICH SA (CH) | 2010-04-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120003170-A1 | CHEMICALLY STABLE INGREDIENTS AS LEMON ODORANT | NISCH, TAS2R5, ODC1 | KMT2A 2309/4885MEN1 466/4885CYP3A4 767/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.